X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (396) 396
Conference Proceeding (71) 71
Publication (14) 14
Patent (11) 11
Book Chapter (9) 9
Book / eBook (4) 4
Newspaper Article (3) 3
Paper (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (159) 159
index medicus (116) 116
male (86) 86
female (77) 77
oncology (72) 72
middle aged (70) 70
aged (62) 62
adult (47) 47
animals (39) 39
cancer (39) 39
aged, 80 and over (33) 33
apoptosis (32) 32
medicine & public health (31) 31
immunohistochemistry (30) 30
expression (28) 28
tumors (28) 28
cell biology (27) 27
analysis (26) 26
gastroenterology & hepatology (26) 26
pathology (26) 26
prognosis (26) 26
research (26) 26
surgery (26) 26
cell line, tumor (25) 25
survival (24) 24
gene expression (21) 21
mice (20) 20
biochemistry & molecular biology (19) 19
biliary tract cancer (18) 18
health aspects (17) 17
chemotherapy (16) 16
in-vitro (16) 16
retrospective studies (16) 16
treatment outcome (16) 16
antineoplastic agents - therapeutic use (15) 15
epigenetics (15) 15
antineoplastic agents - pharmacology (14) 14
chemistry (14) 14
internal medicine (14) 14
adolescent (13) 13
atherosclerosis (13) 13
cell proliferation (13) 13
diagnosis (13) 13
differentiation (13) 13
growth (13) 13
medical prognosis (13) 13
proliferation (13) 13
therapy (13) 13
biopsy (12) 12
kaplan-meier estimate (12) 12
metastasis (12) 12
mortality (12) 12
proteins (12) 12
risk factors (12) 12
young adult (12) 12
biliary tract neoplasms - pathology (11) 11
biomarkers, tumor - metabolism (11) 11
biotechnology & applied microbiology (11) 11
cancer therapies (11) 11
carcinoma (11) 11
care and treatment (11) 11
colorectal-cancer (11) 11
gene expression regulation, neoplastic - drug effects (11) 11
hematology (11) 11
hepatocellular carcinoma (11) 11
hepatocellular-carcinoma (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
biology (10) 10
carcinoma, hepatocellular - pathology (10) 10
disease-free survival (10) 10
liver cancer (10) 10
liver metastases (10) 10
management (10) 10
medical colleges (10) 10
medicine (10) 10
micrornas - genetics (10) 10
neoplasm staging (10) 10
pancreatic cancer (10) 10
patients (10) 10
rna, messenger - metabolism (10) 10
time factors (10) 10
cell proliferation - drug effects (9) 9
cell survival (9) 9
cell survival - drug effects (9) 9
chemistry, multidisciplinary (9) 9
colorectal cancer (9) 9
cytotoxicity (9) 9
dna methylation (9) 9
gene expression regulation, neoplastic (9) 9
gene-expression (9) 9
genetic aspects (9) 9
hematology, oncology and palliative medicine (9) 9
inflammation (9) 9
kinases (9) 9
liver neoplasms - pathology (9) 9
research article (9) 9
review (9) 9
stem cells (9) 9
studies (9) 9
usage (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cell Adhesion & Migration, ISSN 1933-6918, 01/2019, Volume 13, Issue 1, pp. 76 - 82
Cellular migration is essential in diverse physiological and pathophysiological processes. Here, we present a protocol for quantitative analysis of migration... 
ouabain | confluence measurement | continuous measurement | cytochalasin D | Migration | high-throughput | gap-closure assay | epidermal growth factor | non-endpoint | A549 human lung carcinoma cells | IN-VITRO | CELL BIOLOGY | cytochalasin d | a549 human lung carcinoma cells | migration
Journal Article
Human Pathology, ISSN 0046-8177, 2017, Volume 65, pp. 41 - 52
Epigenetic factors contribute to carcinogenesis, tumor promotion and chemoresistance. Histone deacetylases (HDACs) are epigenetic regulators that primarily... 
Pathology | Expression analysis | Proliferation | Overall survival | Disease-free survival | HDAC | Pancreatic neuroendocrine tumor | CANCER-CELLS | DUCTAL ADENOCARCINOMA | ACETYLATION | PATHOLOGY | MAINTENANCE | CLINICOPATHOLOGICAL PARAMETERS | GROWTH | 1 EXPRESSION | HUMAN HEPATOCELLULAR-CARCINOMA | PROGRESSION | Immunohistochemistry | Histone Deacetylases - analysis | Predictive Value of Tests | Up-Regulation | Cell Proliferation | Histone Deacetylase 2 - analysis | Mitosis | Humans | Middle Aged | Male | Neuroendocrine Tumors - enzymology | Neoplasm Grading | Time Factors | Aged, 80 and over | Adult | Female | Pancreatic Neoplasms - mortality | Neuroendocrine Tumors - pathology | Sirtuin 1 - analysis | Biomarkers, Tumor - analysis | Pancreatic Neoplasms - pathology | Risk Factors | Kaplan-Meier Estimate | Pancreatic Neoplasms - enzymology | Disease-Free Survival | Histone Deacetylase 1 - analysis | Neuroendocrine Tumors - mortality | Aged | Neuroendocrine Tumors - therapy | Pancreatic Neoplasms - therapy | Epigenetic inheritance | Chromatin | Genetic engineering | Patient outcomes | Tumors | Enzymes | Immunoglobulins | Statistical analysis | Breast cancer | Multivariate analysis | Gene expression | Studies | Liver cancer | Survival analysis | Cell growth | Medical prognosis | Rodents | Cell cycle | Epigenetics | Tumorigenesis | Diabetes | Apoptosis
Journal Article
Oncogene, ISSN 0950-9232, 09/2010, Volume 29, Issue 35, pp. 4885 - 4895
The Hedgehog (Hh) pathway regulates cell proliferation and survival and contributes to tumorigenesis. We investigated the expression and function of this... 
GLI transcription factors | apoptosis | chronic lymphocytic leukemia | hedgehog | stromal cells | STEM-CELLS | SONIC HEDGEHOG | BIOCHEMISTRY & MOLECULAR BIOLOGY | NEURAL-TUBE | CANCER | CELL BIOLOGY | B-CELLS | IN-VITRO | ONCOLOGY | GENETICS & HEREDITY | CD38 EXPRESSION | ZAP-70 EXPRESSION | MARROW STROMAL CELLS | HEDGEHOG SIGNALING PATHWAY | Oncogene Proteins - genetics | Apoptosis - drug effects | Humans | Hedgehog Proteins - metabolism | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | RNA, Messenger - metabolism | Smoothened Receptor | Trans-Activators - genetics | Veratrum Alkaloids - pharmacology | B-Lymphocytes - pathology | Gene Expression Regulation, Neoplastic - drug effects | B-Lymphocytes - metabolism | Cell Survival - drug effects | B-Lymphocytes - cytology | Genetic Predisposition to Disease | RNA, Messenger - genetics | Pyrimidines - pharmacology | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Oncogene Proteins - antagonists & inhibitors | B-Lymphocytes - drug effects | Animals | Leukemia, Lymphocytic, Chronic, B-Cell - metabolism | Receptors, G-Protein-Coupled - antagonists & inhibitors | Cell Line, Tumor | Pyridines - pharmacology | Receptors, G-Protein-Coupled - genetics | Zinc Finger Protein GLI1 | Trans-Activators - antagonists & inhibitors | Chronic lymphocytic leukemia | Transcription factors | Physiological aspects | Cellular signal transduction | Genetic aspects | Research | Health aspects | Risk factors | Apoptosis | Signal transduction | Cellular biology | Gene expression | Lymphocytes | Leukemia
Journal Article
Journal of Clinical Pathology, ISSN 0021-9746, 04/2016, Volume 69, Issue 4, pp. 326 - 330
Journal Article
ANNALS OF ONCOLOGY, ISSN 0923-7534, 11/2019, Volume 30, Issue 11, pp. 1796 - 1803
Background: FIRE-3 compared first-line therapy with FOLFIRI plus either cetuximab or bevacizumab in 592 KRAS exon 2 wild-type metastatic colorectal cancer... 
colorectal cancer | ONCOLOGY | SUBTYPES | CMS | bevacizumab | cetuximab | OPEN-LABEL
Journal Article
Gut, ISSN 0017-5749, 01/2016, Volume 65, Issue 1, pp. 134 - 143
IntroductionRadiofrequency ablation (RFA), a palliative therapeutic option for solid hepatic tumours, stimulates localised and systemic antitumour cytotoxic T... 
HEPATOCELLULAR-CARCINOMA | THERMAL ABLATION | IMMUNE-SYSTEM | DENDRITIC CELLS | ANTIGEN-PRESENTING CELLS | COLORECTAL LIVER METASTASES | LASER-INDUCED THERMOTHERAPY | CPG DNA | GASTROENTEROLOGY & HEPATOLOGY | T-LYMPHOCYTES | RADIOFREQUENCY ABLATION | Neoplasm Transplantation | Rabbits | Carcinoma, Hepatocellular - mortality | Catheter Ablation | Liver Neoplasms - immunology | Treatment Outcome | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Liver Neoplasms - therapy | Liver Neoplasms, Experimental - mortality | Liver Neoplasms, Experimental - therapy | Random Allocation | Liver Neoplasms - mortality | Toll-Like Receptor 9 - agonists | Animals | T-Lymphocytes, Cytotoxic - metabolism | Carcinoma, Hepatocellular - pathology | Cell Line, Tumor | Female | Liver Neoplasms - pathology | Carcinoma, Hepatocellular - immunology | Carcinoma, Hepatocellular - therapy | Liver Neoplasms, Experimental - pathology | Oligodeoxyribonucleotides - therapeutic use | Usage | Oligonucleotides | Radiofrequency ablation | Dosage and administration | Research | Interleukin-8 | Antineoplastic antibiotics | Antigens | Drinking water | Cytokines | Melanoma | Clinical trials | Cytotoxicity | Vaccines | Radios | Cancer therapies | Liver cancer | Ethics | Chemotherapy | Immunology | Lymphocytes | Gangrene | Tumor necrosis factor-TNF | Tumors
Journal Article
Journal Article
Journal Article
WORLD JOURNAL OF GASTROENTEROLOGY, ISSN 1007-9327, 07/2019, Volume 25, Issue 25, pp. 3136 - 3150
Journal Article